To explore the exact mechanism of Sal B causing the changes of metabolites by FoxO signaling pathway, we also introduced AMP-activated protein kinase (AMPK), an upstream modulator of FoxO1 activity [29], could inhibit the progression of liver fibrosis by activating its downstream targets such as FoxO1 [30]. The gene discussed is FOXO1; the disease is Hepatic fibrosis.